Results 261 to 270 of about 3,569,315 (302)

Drug utilization patterns as indicators

Pharmacoepidemiology and Drug Safety, 1998
openaire   +2 more sources

The PSRO and drug utilization review

American Journal of Health-System Pharmacy, 1973
openaire   +2 more sources

Drug utilization evaluation

Journal of General Internal Medicine, 1995
J T, Farrar, B L, Strom
openaire   +2 more sources

Outcome of Combining Epigenetic Drugs With Other Treatments in the Clinic

Medical Epigenetics, 2016
Paromita Raha
exaly  

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
Melissa McDiarmid, Thomas H Connor
exaly  

Drug utilization

2013
openaire   +1 more source

Association of Insurance With Cancer Care Utilization and Outcomes

Ca-A Cancer Journal for Clinicians, 2008
Rebecca L. Siegel, Ahmedin Jemal, Carol E DeSantis   +2 more
exaly  

Drug utilization.

Pennsylvania medicine, 1998
openaire   +3 more sources

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
Jérôme W Yates, J W Yates
exaly  

Drug Utilization Research

2008
Research in drug utilization began to develop in the 1960s as a result of growing concerns about unintended drug effects and the cost of drugs. Drug utilization studies had been conducted previously by pharmaceutical companies, but the data from these studies were, in general, not available to the authorities, healthcare providers, or researchers.
openaire